Lanean...
Sorafenib for the Treatment of Hepatocellular Carcinoma: A Systematic Review
BACKGROUND: Sorafenib, a drug that inhibits Raf serine/threonine kinases mediating cell proliferation and receptor tyrosine kinases involved in angiogenesis, is approved for the treatment of advanced hepatocellular carcinoma (HCC). AIMS: To explore the efficacy and safety of sorafenib for treating a...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2012
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3596114/ https://ncbi.nlm.nih.gov/pubmed/22451120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-012-2136-1 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|